Individual skill

the-lancet-oncology

Use when targeting The Lancet Oncology or deciding whether a clinical oncology manuscript fits this venue. Encodes the journal's fit, framing, method-and-evidence bar, house style, official-submission re-check, and desk-reject heuristics.

English-NaturalScience-Journal-Skills/skills/the-lancet-oncology/SKILL.md

Read pinned source

Source commit 932eb23331721b16e967c59f093781be1928b498

What was checked

Matches the observed repository HEAD
Yes
Scanner rules are current
No
Repository scan complete
No
Skill scan complete
Yes
Observed behavior
Not checked yet
Last checked
Nov 9, 2026

These are observations at the recorded commit, not a guarantee of safety. Review the source before running it.

Install this skill

Choose an agent in your Stack or copy a command below. Commands fetch the pinned commit and copy only this skill directory. Existing destinations are refused. Copying a command does not install anything.

An install command is unavailable: current rules, complete repository and skill scans, an eligible behavior level and a permitted license are required.

Repository context

Repository stars (not skill ratings)
1,409
Repository last updated
Sep 27, 2026
License
MIT

Observed agent integration: No specific integration evidence. Standard SKILL.md installation does not imply verified compatibility.

Files and excerpt

File metadata and permitted, redacted excerpts come from the recorded scan. Source links are pinned to that commit.

Browse files
Read excerpt

# The Lancet Oncology (the-lancet-oncology)

## Journal positioning

The Lancet Oncology is a flagship specialty title in the Lancet family and one of the world's most prestigious clinical oncology journals, published by Elsevier. It publishes practice-changing cancer clinical trials, oncology policy, cancer epidemiology, and translational cancer research that is directly relevant to the clinical management of cancer at a global level. The journal maintains the Lancet family's editorial standards: rigorous trial registration, CONSORT compliance, equity and global-health consciousness, and a bias toward findings that shift oncology practice or inform cancer policy. Studies that are methodologically sound but incremental—small improvements in surrogate endpoints, single-arm studies without historical context, or descriptive epidemiology without actionable implications—are unlikely to succeed here.

This skill is a **fit / venue-selection / re-framing** tool. It does not replace the journal's current official submission guidelines. Before submitting, re-check the live author instructions on the Lancet/Elsevier site or submission system.

## When to trigger

- The author names The Lancet Oncology as the target venue for a phase III cancer trial, cancer epidemiology analysis, or oncology-policy paper.
- A cancer clinical trial has results that could change standard of care across a patient population at international scale.
- A cancer-burden or cancer-control analysis has policy implications for global or regional oncology systems.
- The author needs The Lancet Oncology's desk-reject risks and credible alternatives before submitting.
Back to top